Question 1

What is cereno scientefic AB?

Accepted Answer

Cereno Scientific AB is a clinical-stage biotech company that develops treatments for cardiovascular diseases,Cereno Scientific develops treatments for rare and common cardiovascular diseases, including those with thrombosis, fibrosis, high pressure, and inflammation.

Question 2

What market has Cereno Scientific's B share (CRNO B) been traded?

Accepted Answer

Cereno Scientific's B share (CRNO B) has been traded on Nasdaq First North Growth Market since June 2023.

Question 3

Where is Cereno Scientific's headquarters located?

Accepted Answer

Cereno Scientific's headquarters are in AstraZeneca's BioVenture Hub in Sweden.

Question 4

What inspired Rahul Agarwal to join Cereno Scientific, and what excites him most about his role?

Accepted Answer

Dr. Agarwal expressed his excitement about joining Cereno Scientific, highlighting the company’s promising drug candidate portfolio and platform aimed at transforming treatment for cardiovascular diseases.
He noted that Cereno's focus on pulmonary arterial hypertension (PAH) and thrombosis prevention could lead to a significant shift in patient care.
He emphasized the portfolio's potential for reverse remodelling in PAH and its ability to prevent thrombosis without the associated bleeding risks, which he considers highly clinically relevant.

Institution	Course
Free University of Berlin, Germany and Cornell University	MD degree
Buckinghamshire New University, UK	MBA

Company	Role
CMO	Cardior
AstraZeneca	VP and Global Medicines Leader
Bayer HealthCare	Global Director of Medical Affairs and Clinical Development
Cereno Scientific	Chief Medical Officer and Head R&D

Rahul Agrawal Snapshot

Rahul Agrawal

Is This Your Account?